GENE ONLINE|News &
Opinion
Blog

2026-07-08|

Tariq and Bhatt Argue Physicians Must Retain Final Authority Over AI Clinical Integration

by GOAI
Share To

Afnan R. Tariq and Ami Bhatt argue that physicians must maintain primary responsibility for the integration of artificial intelligence into clinical practice to ensure patient safety. The authors contend that the current debate surrounding AI licensure overlooks the fundamental purpose of medical regulation, which centers on the accountability of the practitioner for patient outcomes.

The authors emphasize that as AI tools increasingly influence diagnostic and treatment decisions, the medical profession must establish clear frameworks for oversight. They suggest that because physicians remain legally and ethically accountable for the results of patient care, they must lead the implementation process. By positioning the physician as the final authority in AI-assisted medicine, the authors propose that the medical community can better manage the risks associated with automated technology. This perspective shifts the focus of the licensure discussion from the software itself to the professional standards governing the clinicians who utilize these tools in daily practice.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: July 8, 2026

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
Codon-Pair Deoptimization Attenuates FMDV in Swine but Fails to Induce Protective Immunity
2026-07-16
Grady Emerson and Maddie DiMaria Named 2025-2026 Gatorade National Players of the Year
2026-07-15
Longitudinal Network Analysis Tracks Evolving Symptom Clusters in Elderly Chronic Gastritis Patients
2026-07-15
Taiwan Study Finds Allergic Disease Multimorbidity Patterns Shift During Elementary School Years
2026-07-15
NHS Data Shows 30-Fold Disparity in Specialty Training Success Rates Between Ethnic Groups
2026-07-15
New Jersey Meteorite Confirmed to Contain Extraterrestrial Chemical Signatures
2026-07-15
Vanda Pharmaceuticals Sponsors No. 47 IndyCar to Mark 47-Year Gap in Motion Sickness Treatments
2026-07-15
Scroll to Top